S100A6 and Miyoshi myopathy: White et al. recently extended this work using the new technology SWATH-MS, finding that protein S100A6 was upregulated 2.5-fold and 2.1-fold in MM versus ADCA and MM versus benign reactive effusions, respectively [38].